16:30 EST Durect falls 71% to 75c after Phase 2B study misses primary endpint
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on DRRX:
- DRRX Earnings this Week: How Will it Perform?
- Largest borrow rate increases among liquid names
- These 2 ‘Strong Buy’ Penny Stocks Have Massive Upside Potential, Says Oppenheimer
- Oppenheimer pharmaceuticals analysts to hold an analyst/industry conference call
- Durect management to meet with Oppenheimer
